Related references
Note: Only part of the references are listed.Quantification of trans-resveratrol and its metabolites in rat plasma and tissues by HPLC
M. Emilia Juan et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2010)
Hypercholesterolemia in rats impairs the cholinergic system and leads to memory deficits
Celine Ullrich et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2010)
CD40/CD40L contributes to hypercholesterolemia-induced microvascular inflammation
Karen Y. Stokes et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Familial hypercholesterolemia and lipoprotein(a) hyperlipidemia as independent and combined cardiovascular risk factors
Evelyn Orso et al.
ATHEROSCLEROSIS SUPPLEMENTS (2009)
Mechanisms of resveratrol-induced platelet apoptosis
Kuan H. Lin et al.
CARDIOVASCULAR RESEARCH (2009)
Resveratrol attenuates the expression of HMG-CoA reductase mRNA in hamsters
Il Jin Cho et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Specific SIRT1 Activation Mimics Low Energy Levels and Protects against Diet-induced Metabolic Disorders by Enhancing Fat Oxidation
Jerome N. Feige et al.
CELL METABOLISM (2008)
Resveratrol attenuates thromboxane A2 receptor agonist-induced platelet activation by reducing phospholipase C activity
Yu-Min Yang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Molecular mechanism of apoptosis induction by resveratrol, a natural cancer chemopreventive agent
Enguo Fan et al.
INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH (2008)
CD40-CD40 ligand interactions in oxidative stress, inflammation and vascular disease
Muhammad Rizvi et al.
TRENDS IN MOLECULAR MEDICINE (2008)
Release of biologically active CD154 during collection and storage of platelet concentrates prepared for transfusion
J. Kaufman et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Statin and resveratrol in combination induces cardioprotection against myocardial infarction in hypercholesterolemic rat
Suresh Varma Penumathsa et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2007)
Low-density lipoprotein-lowering medication and platelet function
Patrizia Ferroni et al.
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS (2006)
The relative role of PLCβ and PI3Kγ in platelet activation
LR Lian et al.
BLOOD (2005)
Pterostilbene, a new agonist for the peroxisome proliferator-activated receptor α-isoform, lowers plasma lipoproteins and cholesterol in hypercholesterolemic hamsters
AM Rimando et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2005)
Dietary wine phenolics catechin, quercetin, and resveratrol efficiently protect hypercholesterolemic hamsters against aortic fatty streak accumulation
C Auger et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2005)
Effect of atorvastatin upon platelet activation in hypercholesterolemia, evaluated by flow cytometry
M Labios et al.
THROMBOSIS RESEARCH (2005)
Effect of Atorvastatin on the expression of CD40 ligand and P-selectin on platelets in patients with hypercholesterolemia
YS Hwang et al.
AMERICAN JOURNAL OF CARDIOLOGY (2004)
Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus - Relationships to cardiovascular disease and risk factor intervention
HS Lim et al.
CIRCULATION (2004)
Hypolipidemic action of dietary resveratrol, a phytoalexin in grapes and red wine, in hepatoma-bearing rats
D Miura et al.
LIFE SCIENCES (2003)
CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation
DP Inwald et al.
CIRCULATION RESEARCH (2003)
Upregulation of CD40 and CD40 ligand (CD154) in patients with moderate hypercholesterolemia
CD Garlichs et al.
CIRCULATION (2001)
Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease - Effects of an early invasive or noninvasive strategy
E Lindmark et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Apo A-I binding to platelets detected by flow cytometry
D Ozsavci et al.
THROMBOSIS RESEARCH (2001)
Minireview -: Biological effects of resveratrol
L Frémont
LIFE SCIENCES (2000)
Share Paper
